Daniel Ryabo, PharmD candidate 2025; Ifra Khan, PharmD candidate 2025; Aslan Amirov, PharmD candidate 2025; Mahmoud Shahin, PharmD candidate 2025; Tina Zerilli, PharmD

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.